Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Roadmap to Parenthood: A Study about Fertility and Family-Building After Cancer
Glossary on
off
Printer Friendly Page Roadmap to Parenthood: A Study about Fertility and Family-Building After Cancer

Roadmap to Parenthood: A Study about Fertility and Family-Building After Cancer

Clinicaltrials.gov identifier:
NCT06050135

Surveys, Registries, Interviews
A survey for people aged 18-45, assigned female at birth, and history of a cancer diagnosis

Study Contact Information:

Research coordinator: Sumitra Ananth

Contact: roadmaptoparenthood@stanford.edu


Roadmap to Parenthood: A Study about Fertility and Family-Building After Cancer

About the Study

Cancer treatments can cause infertility, early menopause, or problems getting pregnant. Family building after cancer may require reproductive medicine, surrogacy, or adoption. We are conducting this study to evaluate an online tool developed to educate and provide support to women and people assigned female at birth who are interested in family building after cancer. This study involves the completion of four online surveys. All study procedures are done remotely.

What the Study Involves

The Roadmap to Parenthood study is a being conducted at Stanford University School of Medicine. We are testing the efficacy of an online “decision aid and planning tool” for family building after cancer. All study participants will complete four online surveys, each of which take 30-45 minutes, over the course of 12 months. Participants will be compensated $30 for the completion of each study survey, receiving a total of $120 for completing all four surveys.

Complete the recruitment form to participate: https://redcap.link/kdxlyxwu

 

Learn more about the study and the study team: roadmaptoparenthood.stanford.edu

 

Lead Researcher

PI: Catherine Benedict, PhD
Institution: Stanford University School of Medicine
Contact: cbenedict@stanford.edu

This Study is Open To:

People who: 

  • Assigned female at birth
  • Aged 18-45
  • History of a cancer diagnosis
  • Completed primary cancer treatment (excluding long-term endocrine or maintenance therapies)
This Study is Not Open To:

People who are currently undergoing chemotherapy, radiation, or planned surgery as primary treatment for cancer